Hong Kong
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 493.46 M
|
Dec. 31, 2023 | USD 0.67 | 1.15% |
|
Hong Kong |
|
2 |
USD 380.49 M
|
Dec. 31, 2023 | USD 1.48 | 0.68% |
|
Hong Kong |
|
3 |
USD 338.17 M
|
Dec. 31, 2023 | USD 0.93 | 2.39% |
|
Hong Kong |
|
4 |
USD 328.45 M
|
Dec. 31, 2023 | USD 0.38 | 2.08% |
|
Hong Kong |
|
5 |
USD 181.02 M
|
Dec. 31, 2023 | USD 0.25 | -2.07% |
|
Hong Kong |
|
6 |
USD 168.82 M
|
Dec. 31, 2023 | USD 0.41 | 0.30% |
|
Hong Kong |
|
7 |
USD 122.31 M
|
March 31, 2024 | USD 0.46 | 4.31% |
|
Hong Kong |
|
8 |
USD 100.78 M
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
|
9 |
USD 69.19 M
|
Dec. 31, 2023 | USD 1.07 | 3.09% |
|
Hong Kong |
|
10 |
USD 51.74 M
|
Dec. 31, 2023 | USD 0.52 | 0.23% |
|
Hong Kong |
|
11 |
USD 45.92 M
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
Hong Kong |
|
12 |
USD 45.07 M
|
Dec. 31, 2023 | USD 0.44 | 1.16% |
|
Hong Kong |
|
13 |
USD 40.34 M
|
March 31, 2024 | USD 0.27 | 0.46% |
|
Hong Kong |
|
14 |
USD 38.07 M
|
Dec. 31, 2023 | USD 0.43 | -0.61% |
|
Hong Kong |
|
15 |
USD 20.87 M
|
Dec. 31, 2023 | USD 0.19 | -0.02% |
|
Hong Kong |
|
16 |
USD 19.79 M
|
Dec. 31, 2023 | USD 0.80 | 2.57% |
|
Hong Kong |
|
17 |
USD 10.81 M
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
18 |
USD 2.14 M
|
Dec. 31, 2023 | USD 0.16 | -3.21% |
|
Hong Kong |
|
19 |
USD -4.30 M
|
June 30, 2024 | USD 3.80 | 0.53% |
|
Hong Kong |
|
20 |
USD -34.24 M
|
Dec. 31, 2023 | USD 0.13 | -0.02% |
|
Hong Kong |
|
21 |
USD -62.72 M
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
22 |
USD -78.69 M
|
Dec. 31, 2023 | USD 0.37 | 4.31% |
|
Hong Kong |
|
23 |
USD -881.71 M
|
Dec. 31, 2023 | USD 17.19 | 2.12% |
|
Hong Kong |
The Healthcare company in Hong Kong with the highest Net Income is China Resources Pharmaceutical Group Limited (HKSE: 3320.HK) at USD 493.46 M.
The Healthcare company in Hong Kong with the lowest Net Income is BeiGene, Ltd. (HKSE: 6160.HK) at USD -881.71 M.
The top 10 Healthcare companies in Hong Kong by Net Income are China Resources Pharmaceutical Group Limited, The United Laboratories International Holdings Limited, China Medical System Holdings Limited, Sino Biopharmaceutical Limited, China Traditional Chinese Medicine Holdings Co. Limited, SSY Group Limited, Alibaba Health Information Technology Limited, HUTCHMED (China) Limited, Beijing Tong Ren Tang Chinese Medicine Company Limited and Modern Dental Group Limited.
The bottom 10 Healthcare companies in Hong Kong by Net Income are BeiGene, Ltd., Sirnaomics Ltd., Prenetics Global Limited, SinoMab BioScience Limited, Regencell Bioscience Holdings Limited, Lee's Pharmaceutical Holdings Limited, Frontage Holdings Corporation, Guangdong Hybribio Biotech Co.,Ltd., Jilin Province Huinan Changlong Bio-pharmacy Company Limited and Tycoon Group Holdings Limited.